Scientists hunt for blood test to predict nerve disease severity in kids
NCT ID NCT07476365
Summary
This study aims to find biological markers in the blood or skin that can predict how severe Charcot-Marie-Tooth disease type 1A (CMT1A) will become. Researchers will study 70 young people aged 10-30 with CMT1A over one year, comparing their health scores with samples from animal models. The goal is to find reliable early signs of disease progression to help future drug trials start treatment sooner.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CMT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Medical Centre
RECRUITINGGöttingen, 37075, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.